Abstract
Background
Age, female sex, and obesity are considered to be risk factors for gallstone disease. The role of type 2 diabetes (T2D) in gallstone formation is still uncertain, and data in Indians is limited.
Objectives
This is a case–control study to determine the prevalence of gallstones (GS) in patients with T2D, risk factors, and the relative risk compared with subjects without diabetes, selected from the general population.
Methods
Among 450 cases with T2D of a ≥2-year duration, 377 (88.8 %) participated. Diagnosis of GS was made at ultrasonography and history of cholecystectomy for GS. Controls were selected from the general population and diabetes excluded by oral glucose tolerance test. Cases and controls were matched for age, gender, and body mass index (BMI).
Results
Gallstones were seen in 67 (17.7 %) cases compared to 40 (5.8 %) in controls (p = 0.001). Prevalence increased with increasing age with peak in the sixth decade (23.4 % in cases and 4.4 % in controls (p = 0.001) and was higher in women (27.9 %) in cases and (7.8 %) in controls, (p = 0.001). In univariate analysis, risk factors for GS included age, female sex, BMI, multiparity, family history of GS, and high triglycerides and cholesterol with low high-density lipoprotein cholesterol. In multivariate analysis, age, (relative risk [RR] 1.54, confidence interval [CI] 1.1–2.1), female sex (RR 1.6, CI 1.0–1.9), and BMI (RR 1.5, CI 1.3–2.5) were the independent risk factors in gallstone formation.
Conclusion
Patients with T2D had higher probability of having GS compared to the general population. Increasing age, female sex, and higher BMI were independently associated with gallstone disease.
Similar content being viewed by others
References
Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.
Anjana RM, Pradeepa R, Deepa M, et al; ICMR–INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdiaDIAbetes (ICMR-INDIAB) study. Diabetologia. 2011;54:3022–7.
Deepa R, Sandeep S, Mohan V. Abdominal obesity, visceral fat and type 2 diabetes—Asian Indian phenotype. In: Mohan V, Gundu HR, editors. Type 2 Diabetes in South Asians: Epidemiology, Risk Factors and Prevention. New Delhi: Jaypee Brothers Medical Publishers; 2006. p. 138–52.
Joshi R. Metabolic syndrome—emerging clusters of the Indian phenotype. J Assoc Physicians India. 2003;51:445–6.
Zargar AH, Khan AK, Masoodi SR, et al. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. Diabetes Res Clin Pract. 2000;47:135–46.
Sarin SK, Negi VS, Dewan R, et al. High family prevalence of gallstones in the first degree relatives of gallstone patients. Hepatology. 1995;22:138–41.
Sharma MP, Duphare HV, Nijhawan S, Dasarathy S. Gallstone disease in north India: clinical and ultrasound profile in a referral hospital. J Clin Gastroenterol. 1990;12:547–9.
Khuroo MS, Mahajan R, Zargar SA, Sapru S. Prevalence of biliary tract disease in India: a sonographic study in adult population in Kashmir. Gut. 1989;30:201–5.
Olokoba AB, Bojuwoye BJ, Olokoba LB, Braimoh KT, Inikori AK. Gallstone disease and type-2 diabetes mellitus—the link. J Coll Physicians Surg Pak. 2007;17:594–7.
De Santis A, Attili AF, Corradini SG, et al. Gallstones and diabetes: a case control study in a free living population sample. Hepatology. 1997;25:787–90.
Jorgensen T. Gallstone in Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut. 1989;30:528–34.
Barbara L, Sama C, Morsellilabate AM, et al. A population study on the prevalence of gallstone disease. The Sirmione study. Hepatology. 1987;7:913–7.
Altman DG. Clinical trials. In: Altman DG, editor. Practical Statistics for Medical Research. Madras: Chapman and Hall; 1991. p. 441–76.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5–S10.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57.
Elmehdawi RR, Elmajberi SJ, Behieh A, Elramli A. Prevalence of gallbladder stones among type 2 diabetic patients in Benghazi Libya: a case control study. Libyan J Med. 2009;4:27–30.
Saxena R, Sharma S, Dubey DC. Gallbladder disorder in type 2 diabetes mellitus cases. J Hum Ecol. 2005;18:169–79.
Haffner SM, Diehl AK, Mitchell BD, et al. Increased prevalence of clinical gallbladder disease in subjects with non insulin dependent diabetes mellitus. Am J Epidemiol. 1990;132:327–35.
Chi ML, Chung T, Chung YL, Chu CC, Meng LL, Jom HL. A population based cohort study of symptomatic gallstones disease in diabetic patients. World J Gastroenterol. 2012;18:1652–9.
Gitelson S, Oppenheim D, Schwartz A. Size of the gallbladder in patients with diabetes mellitus. Diabetes. 1969;18:493–8.
Braverman DZ. The lack of effect of metachlopramide on gallbladder and contraction in diabetic cholecystoparesis. Am J Gastroenterol. 1986;81:960–2.
Fischer RS, Rock E, Malmud LS, et al. Cholinergic effects on gallbladder emptying in humans. Gastroenterology. 1985;89:716–22.
Fischer RS, Rock E, Malmud LS, et al. Gallbladder emptying response to Sham feeding in humans. Gastroenterology. 1986;90:1854–7.
Haber GB, Heaton KW. Lipid composition of bile in diabetics and obesity matched controls. Gut. 1979;20:518–22.
Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gallstone disease. A case control study. Br Med J. 1984;289:521–5.
Sampliner RE, Bennett PH, Comess IR, et al. Gallbladder disease in Pima Indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med. 1970;283:1358–64.
Laakso M, Suhonen M, Julkunen R, Pyorala K. Plasma insulin, serum lipids and lipoproteins in gallstone disease in non-insulin dependent diabetic subjects. A case control study. Gut. 1990;31:344–7.
Ruhl CE, Everhart JE. Association of diabetes, serum insulin and C-peptide with gallbladder disease. Hepatology. 2000;31:299–303.
Conflict of interest
JSS, SAZ, SK, AS, GJ, BAL, SP, BAK, GNY, AS, GMG, and MAK all declare that they have no conflict of interest.
Ethics statement
The study was performed in a manner to conform with the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning Human and Animal Rights, and the authors followed the policy concerning Informed Consent as shown on http://www.springer.com.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sodhi, J.S., Zargar, S.A., Khateeb, S. et al. Prevalence of gallstone disease in patients with type 2 diabetes and the risk factors in North Indian population: A case control study. Indian J Gastroenterol 33, 507–511 (2014). https://doi.org/10.1007/s12664-014-0502-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-014-0502-y